Inventor
CORVALAN JOSE
US14 patents
⚠️ This page may combine multiple inventors who share the name “CORVALAN JOSE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WEBER RICHARD
5 patentsUS9096672B2Aug 4, 2015
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
WEBER RICHARD16 citations92
US9062113B2Jun 23, 2015
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
WEBER RICHARD7 citations83
US9073998B2Jul 7, 2015
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
WEBER RICHARD3 citations73
US10118968B2Nov 6, 2018
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
WEBER RICHARD2 citations72
US9085624B2Jul 21, 2015
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
WEBER RICHARD2 citations62
AMGEN FREMONT INC
4 patentsUS7736644B2Jun 15, 2010
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC77 citations98
US7628986B2Dec 8, 2009
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC119 citations98
US7626012B2Dec 1, 2009
Nucleic acid molecules which encode antibodies that bind CD40
AMGEN FREMONT INC53 citations98
US7618633B2Nov 17, 2009
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
AMGEN FREMONT INC63 citations98
ABGENIX INC
3 patentsUS7338660B2Mar 4, 2008
Methods of treating cancer and enhancing immune responses with antibodies that bind CD40
ABGENIX INC144 citations99
US7563442B2Jul 21, 2009
Antibodies to CD40 and methods of treating cancer and enhancing immune responses
ABGENIX INC62 citations98
US7141653B2Nov 28, 2006
Human monoclonal antibodies to interleukin-5
ABGENIX INC59 citations93